UroGen Pharma Ltd (URGN) — Strategic Asset Allocation Index
UroGen Pharma Ltd (URGN) has a Strategic Asset Allocation Index of 18.2% as of September 2024. Strategic assets (PP&E of $- plus long-term investments of $4.64 Million) total $4.64 Million, measured against net assets of $25.52 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of UroGen Pharma Ltd to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
UroGen Pharma Ltd Strategic Asset Allocation Index (2013–2021)
This chart shows how UroGen Pharma Ltd's Strategic Asset Allocation Index has evolved across 9 annual periods from 2013 to 2021. As of September 2024, the index stands at 18.2%, representing strategic assets of $4.64 Million against net assets of $25.52 Million USD. See financial agility of UroGen Pharma Ltd to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for UroGen Pharma Ltd (2013–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for UroGen Pharma Ltd from 2013 to 2021, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see URGN market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 31.4% | $2.64 Million | $1.97 Million | $675.00K | $8.41 Million | ▲ +25.1 pp |
| 2020 | 6.3% | $6.10 Million | $4.20 Million | $1.89 Million | $96.36 Million | ▼ -23.2 pp |
| 2019 | 29.5% | $53.27 Million | $4.71 Million | $48.55 Million | $180.30 Million | ▲ +28.5 pp |
| 2018 | 1.1% | $948.00K | $948.00K | $- | $90.09 Million | ▼ -0.1 pp |
| 2017 | 1.2% | $805.00K | $805.00K | $- | $68.52 Million | ▼ -3.4 pp |
| 2016 | 4.5% | $741.00K | $741.00K | $- | $16.31 Million | ▲ +3.0 pp |
| 2015 | 1.5% | $259.00K | $259.00K | $- | $17.15 Million | ▼ -0.5 pp |
| 2014 | 2.0% | $71.00K | $71.00K | $- | $3.47 Million | ▼ -0.8 pp |
| 2013 | 2.8% | $77.00K | $77.00K | $- | $2.74 Million | — |